Updates are available Correction dated 2024-12-20

Article History

Received: 8 October 2024

Accepted: 10 October 2024

First Online: 12 November 2024

Change Date: 18 December 2024

Change Type: Update

Change Details: The original online version of this article was revised: In the abstract section, the second sentence was incorrectly written as “Most women survive, but over 40,000 women a year still die of their disease National Cancer Institute [Internet]. [cited 2024 Nov 4]. Cancer of the Breast (Female) - Cancer Stat Facts. Available from:

Change Details: https://seer.cancer.gov/statfacts/html/breast.html

Change Details: ” but should read as “Most women survive, but over 40,000 women a year still die of their disease (1)”

Change Date: 20 December 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s10549-024-07572-8

Conflict of interest

: DY reports research funding from Boehringer Ingelheim and Fusion Pharmaceuticals; and is a consultant for Martell Diagnostics. CH reports institutional research funding from AstraZeneca, Gilead, Seagen/Pfizer and Olema; individual consulting fees for running ad boards, moderating lectures, speaking/presenting fees from AstraZeneca, Seagen/Pfizer, Gilead and Olema; and travel support from Olema. JG is an executive employee of Dana Faber Cancer Institute; participation on Fiduciary Board at American Association for Cancer Research; and participation on the Scientific Advisory Board at The James P. Wilmot Foundation, Inc. and Earli Inc. LE reports funding from Merck & Co.; participation on an advisory board for Blue Cross Blue Shield; and personal fees from UpToDate; unpaid board member of QLHC. All other authors declare no competing interests.